Home / Health / Merck Settles Gardasil Lawsuits: No Liability Admitted
Merck Settles Gardasil Lawsuits: No Liability Admitted
5 Jun
Summary
- Merck will pay over $50 million to settle more than 200 Gardasil lawsuits.
- The company denies any liability, stating evidence supports vaccine safety.
- The settlement resolves cases alleging autoimmune ailments from the vaccine.
Merck & Co. is settling over 200 lawsuits that alleged its Gardasil cancer vaccine caused autoimmune ailments, agreeing to pay more than $50 million. The pharmaceutical giant has maintained that research supports the safety and efficacy of its HPV vaccines, explicitly denying any liability in the settlement.
The litigation involved claims that Gardasil led to serious health issues, including heart and reproductive system problems, particularly in young women. A prominent case in Los Angeles involving a woman who alleged the vaccine left her in a wheelchair was set to go to trial next month but will now be resolved as part of the broader settlement.
Merck stated that the settlement amount is considerably less than the anticipated costs of defending these cases. The company's annual report indicated a proposed agreement in October to end the litigation, contingent on sufficient participation from those who received the vaccine. Despite claims against the vaccine, mainstream medicine has long heralded Gardasil as safe and effective, with over 900 million doses distributed globally since its introduction approximately 20 years ago.
